TY - JOUR
T1 - Metabolic syndrome
T2 - Evaluation of pathological and therapeutic outcomes
AU - Miranda, Phillippa J.
AU - DeFronzo, Ralph A.
AU - Califf, Robert M.
AU - Guyton, John R.
PY - 2005/1
Y1 - 2005/1
N2 - Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.
AB - Despite its etiologic complexities, regulatory hurdles, and clinical uncertainties, metabolic syndrome must be recognized as a looming danger to public health in the United States. It demands the best efforts of clinicians, bench scientists, regulators, advocates, and clinical trialists to find viable solutions in the near future.
UR - http://www.scopus.com/inward/record.url?scp=12344327474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12344327474&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2004.07.012
DO - 10.1016/j.ahj.2004.07.012
M3 - Article
C2 - 15660031
AN - SCOPUS:12344327474
SN - 0002-8703
VL - 149
SP - 20
EP - 32
JO - American Heart Journal
JF - American Heart Journal
IS - 1
ER -